InnoCan Pharma Corporation (INNPF)
OTCMKTS · Delayed Price · Currency is USD
0.1608
+0.0058 (3.74%)
Sep 2, 2025, 2:57 PM EDT
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of $44.70 million as of September 2, 2025. Its market cap has decreased by -0.53% in one year.
Market Cap
44.70M
Enterprise Value
41.35M
Revenue
28.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 800.37K to 44.70M, an increase of 5,484.86%. That is a compound annual growth rate of 97.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 44.70M | 5.57% |
| Dec 31, 2024 | 42.34M | -32.69% |
| Dec 29, 2023 | 62.91M | 58.58% |
| Dec 30, 2022 | 39.67M | -74.75% |
| Dec 31, 2021 | 157.09M | 220.33% |
| Dec 31, 2020 | 49.04M | 176.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |